-
-
-
-
-
-
-
Humacyte (HUMA) Announces Proposed Public Offering of Common Stock
-
-
-
-
-
-
-
Humacyte, Inc. Announces Pricing of $40.2 Million Public Offering of Common Stock
-
-
-
-
-
-
-
Humacyte (HUMA) Reports Publication of Positive Long-Term Follow-Up Data from Phase 2 Trial of HAV
68,144 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

